Carson Wealth (CWM LLC)’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $693K | Sell |
4,017
-288
| -7% | -$53.4K | ﹤0.01% | 1791 |
|
|
2025
Q4 | $859K | Buy |
4,305
+211
| +5% | +$38.3K | ﹤0.01% | 1586 |
|
|
2025
Q3 | $641K | Buy |
4,094
+1,492
| +57% | +$237K | ﹤0.01% | 1659 |
|
|
2025
Q2 | $395K | Buy |
2,602
+1,227
| +89% | +$164K | ﹤0.01% | 1703 |
|
|
2025
Q1 | $207K | Buy |
1,375
+27
| +2% | +$4.53K | ﹤0.01% | 1906 |
|
|
2024
Q4 | $249K | Sell |
1,348
-194
| -13% | -$37.4K | ﹤0.01% | 1702 |
|
|
2024
Q3 | $304K | Sell |
1,542
-543
| -26% | -$113K | ﹤0.01% | 1534 |
|
|
2024
Q2 | $431K | Buy |
2,085
+476
| +30% | +$108K | ﹤0.01% | 1246 |
|
|
2024
Q1 | $436K | Buy |
1,609
+554
| +53% | +$132K | ﹤0.01% | 1184 |
|
|
2023
Q4 | $249K | Sell |
1,055
-37
| -3% | -$7.28K | ﹤0.01% | 1322 |
|
|
2023
Q3 | $214K | Sell |
1,092
-8
| -0.7% | -$1.64K | ﹤0.01% | 1285 |
|
|
2023
Q2 | $231K | Buy |
1,100
+224
| +26% | +$44.6K | ﹤0.01% | 1199 |
|
|
2023
Q1 | $177K | Buy |
876
+27
| +3% | +$6.12K | ﹤0.01% | 1239 |
|
|
2022
Q4 | $185K | Buy |
849
+102
| +14% | +$22.3K | ﹤0.01% | 1127 |
|
|
2022
Q3 | $147K | Buy |
747
+1
| +0.1% | +$216 | ﹤0.01% | 1167 |
|
|
2022
Q2 | $160K | Buy |
746
+420
| +129% | +$103K | ﹤0.01% | 1135 |
|
|
2022
Q1 | $93K | Buy |
326
+96
| +42% | +$29.6K | ﹤0.01% | 1353 |
|
|
2021
Q4 | $87K | Buy |
+230
| New | +$89.4K | ﹤0.01% | 1342 |
|
|
2021
Q2 | $56K | Hold |
152
| – | – | ﹤0.01% | 1350 |
|
|
2021
Q1 | $56K | Hold |
152
| – | – | ﹤0.01% | 1350 |
|
|
2020
Q4 | $56K | Hold |
152
| – | – | ﹤0.01% | 1350 |
|
|
2020
Q3 | $56K | Hold |
152
| – | – | ﹤0.01% | 1350 |
|
|
2020
Q2 | $56K | Hold |
152
| – | – | ﹤0.01% | 1350 |
|
|
2020
Q1 | $56K | Hold |
152
| – | – | ﹤0.01% | 1350 |
|
|
2019
Q4 | $56K | Hold |
152
| – | – | ﹤0.01% | 1350 |
|
|
2019
Q3 | $56K | Hold |
152
| – | – | ﹤0.01% | 1350 |
|
|
2019
Q2 | $56K | Hold |
152
| – | – | ﹤0.01% | 1350 |
|
|
2019
Q1 | $56K | Sell |
152
-15
| -9% | -$1.97K | ﹤0.01% | 1350 |
|
|
2018
Q4 | $19K | Buy |
167
+108
| +183% | +$13.5K | ﹤0.01% | 1150 |
|
|
2018
Q3 | $8K | Buy |
59
+4
| +7% | +$494 | ﹤0.01% | 1215 |
|
|
2018
Q2 | $6K | Buy |
+55
| New | +$5.95K | ﹤0.01% | 1139 |
|
|
2018
Q1 | – | Sell |
-45
| Closed | -$5K | – | 1428 |
|
|
2017
Q4 | $5K | Hold |
45
| – | – | ﹤0.01% | 1077 |
|
|
2017
Q3 | $5K | Buy |
+45
| New | +$4.62K | ﹤0.01% | 1071 |
|
|
2016
Q4 | – | Sell |
-150
| Closed | -$13K | – | 1110 |
|
|
2016
Q3 | $13K | Buy |
+150
| New | +$12.6K | ﹤0.01% | 631 |
|
Other funds holding CRL
Carson Wealth (CWM LLC)'s CRL Position: Q1 2026 in Review
Carson Wealth (CWM LLC) reduced its Charles River Laboratories (CRL) stake by 6.7% in Q1 2026, selling an estimated $53.4K and leaving 4,017 shares worth $693K. The position accounts for ﹤0.01% of the portfolio, ranked #1791.
Carson Wealth (CWM LLC) first reported a position in CRL in Q3 2016 and has held it in 34 quarters since. The position peaked at $859K in Q4 2025. 559 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Carson Wealth (CWM LLC) held 4,017 shares of Charles River Laboratories worth $693K as of Q1 2026.
- Carson Wealth (CWM LLC) sold 288 Charles River Laboratories shares in Q1 2026, an estimated $53.4K.
- Charles River Laboratories made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1791 holding.
- Carson Wealth (CWM LLC) first reported a position in Charles River Laboratories in Q3 2016 and has held it in 34 quarters since.
- Carson Wealth (CWM LLC)'s Charles River Laboratories position peaked at $859K in Q4 2025.
- 559 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.